04/22/21 Oriflame Investment Holding Plc (ORIFLM) EUR709m equivalent (US$/EUR) 144A/Reg S sr sec notes 2-part. B1/B+/BB- (stable/stable/stable). Via GS/SEB jt glocos and physical books/HSBC jt books, ING as co-manager. List ISE, NY law. No reg rights. trade date 04/22. Settles 05/04.
- USD550m fixed-rate notes due 05/04/26 (5y). NC2 (MWC T+50bp), then at 102.563, 101.281, 100. Equity claw: 2y: 40% at 105.125. 144A CUSIP: 68621CAA7. IPT: mid 5% area. Final px: 5.125%. Priced: 5.125% at 100.
- EUR250m FRN due 05/04/26 (5y). NC1 (MWC B+50bp), then at 101, 100. Reg S ISIN: XS2337349265. IPT: E+450-475bp. Final px: 3moE+425bp. Priced: 3mE+425bp (0% floor) at 100.
Roadshow 04/19-21 (investor call at 2pm UKT 04/19). UOP: along with EUR96m cash on hand, to redeem EUR797m existing notes (EUR475m euro notes, plus EUR24m MWC premium and US$335m dollar notes , plus USD22.1m MWC premium). Biz: international direct selling of beauty products. HQ: Schaffhausen, Switzerland.
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.